Heart Failure

Showing NaN - NaN of 117

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Failure Trial in Worldwide (BMS-986435, Placebo)

Not yet recruiting
  • Heart Failure
  • Atlanta, Georgia
  • +40 more
Nov 3, 2023

Heart Failure Trial in Atlanta, Detroit, Saint Louis (SmartHF application)

Not yet recruiting
  • Heart Failure
  • SmartHF application
  • Atlanta, Georgia
  • +2 more
May 10, 2023

Aortic Stenosis, Mitral Stenosis, Aortic Valve Insufficiency Trial in Canada, Poland, United States (Edwards Aortic and Mitral

Active, not recruiting
  • Aortic Stenosis
  • +4 more
  • Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M
  • Birmingham, Alabama
  • +31 more
Jan 23, 2023

Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction Trial in United

Recruiting
  • Heart Failure
  • +4 more
  • Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System
  • OPTIMIZER™ Smart Mini System
  • Birmingham, Alabama
  • +59 more
Jan 24, 2023

Heart Failure Trial in Worldwide (V-Wave Interatrial Shunt, Control)

Active, not recruiting
  • Heart Failure
  • V-Wave Interatrial Shunt
  • Control
  • Gilbert, Arizona
  • +110 more
Jan 16, 2023

Heart Failure Trial in United States (Canagliflozin 100 mg, Placebo)

Completed
  • Heart Failure
  • Canagliflozin 100 mg
  • Placebo
  • Fort Smith, Arkansas
  • +17 more
Dec 20, 2022

Heart Failure Trial in Worldwide (Ziltivekimab, Placebo)

Not yet recruiting
  • Heart Failure
  • Alexander City, Alabama
  • +420 more
Dec 23, 2022

Heart Failure Trial in Worldwide (sacubitril/valsartan)

Active, not recruiting
  • Heart Failure
  • Loma Linda, California
  • +78 more
Nov 18, 2022

Heart Failure Trial in Atlanta (Thyroid hormone T3, Control Group)

Recruiting
  • Heart Failure
  • Thyroid hormone T3
  • Control Group
  • Atlanta, Georgia
  • +1 more
Nov 14, 2022

Type 2 Diabetes, Chronic Kidney Diseases Trial in Worldwide (Sotagliflozin (SAR439954), Placebo)

Terminated
  • Heart Failure
  • +2 more
  • Birmingham, Alabama
  • +753 more
Sep 30, 2022

Heart Failure, Type 2 Diabetes Trial in Worldwide (Sotagliflozin (SAR439954), Placebo)

Terminated
  • Heart Failure
  • Type 2 Diabetes Mellitus
  • Alexander City, Alabama
  • +465 more
Sep 30, 2022

Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction Trial in Worldwide

Recruiting
  • Heart Failure
  • +4 more
  • Alexander City, Alabama
  • +100 more
Sep 28, 2022

Mitral Regurgitation, Mitral Valve Regurgitation, Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure

Active, not recruiting
  • Mitral Regurgitation
  • +3 more
  • MitraClip System
  • Birmingham, Alabama
  • +85 more
Sep 21, 2022

Heart Failure Trial in United States (Torsemide, Furosemide)

Completed
  • Heart Failure
  • Alexander City, Alabama
  • +59 more
Aug 17, 2022

Breethe Abiomed Recovery regisTry (BART)

Active, not recruiting
  • Cardiopulmonary Bypass
  • +2 more
  • Breethe Oxy-1 System
  • Orlando, Florida
  • +5 more
Jul 22, 2022

Heart Failure Trial in Worldwide (µCor)

Active, not recruiting
  • Heart Failure
  • μCor
  • Sheffield, Alabama
  • +82 more
Jul 8, 2022

Left Ventricular Assist Device (LVAD) and Medical Management

Completed
  • Heart Failure
  • HM II (HeartMate II LVAD)
  • OMM (Optimal Medical Management)
  • Little Rock, Arkansas
  • +51 more
Jun 23, 2022

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
  • Heart Failure
  • Anniston, Alabama
  • +618 more
Jun 3, 2022

Heart Failure Trial in Worldwide (CRT-D)

Completed
  • Heart Failure
  • CRT-D
  • Birmingham, Alabama
  • +71 more
Apr 1, 2022

Heart Failure, Reduced Ejection Fraction Trial in China, United States (INL1, Placebo)

Recruiting
  • Heart Failure
  • Reduced Ejection Fraction
  • Torrance, California
  • +12 more
Mar 28, 2022

Heart Failure Trial in United States (Sodium intervention, Clinical worsening intervention, Educational content)

Recruiting
  • Heart Failure
  • Sodium intervention
  • +2 more
  • Birmingham, Alabama
  • +8 more
Mar 21, 2022

Heart Failure, Diabetes Trial in Atlanta, New Orleans, Philadelphia (Dapagliflozin, Placebo)

Completed
  • Heart Failure
  • Diabetes
  • Atlanta, Georgia
  • +2 more
Mar 17, 2022

Heart Failure, Cardiomyopathy, Dilated Trial in United States (AccuCinch® Ventricular Restoration System)

Active, not recruiting
  • Heart Failure
  • Cardiomyopathy, Dilated
  • AccuCinch® Ventricular Restoration System
  • San Francisco, California
  • +18 more
Mar 14, 2022

Heart Failure, Cardiomyopathy, Dilated Trial in United States (AccuCinch® Ventricular Restoration)

Active, not recruiting
  • Heart Failure
  • Cardiomyopathy, Dilated
  • AccuCinch® Ventricular Restoration
  • San Francisco, California
  • +21 more
Mar 14, 2022

The Product Surveillance Registry REVERSE Post Approval Study

Active, not recruiting
  • Heart Failure
    • Birmingham, Alabama
    • +122 more
    Feb 4, 2022